ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,743,000 Value ($000) $2,248 Avg Close — Range —
Q1 2025
Shares 1,743,000 Value ($000) $2,007 Avg Close — Range —
Q4 2024
Shares 1,958,000 Value ($000) $2,081 Avg Close — Range —
Q3 2024
Shares 3,086,000 Value ($000) $3,608 Avg Close — Range —
Q2 2024
Shares 3,651,000 Value ($000) $3,934 Avg Close — Range —
Q1 2024
Shares 4,021,000 Value ($000) $3,779 Avg Close — Range —
Q4 2023
Shares 2,155,000 Value ($000) $2,117 Avg Close — Range —
Q3 2023
Shares 2,830,000 Value ($000) $2,611 Avg Close — Range —